← All organizations

Corvus Pharmaceuticals, Inc.

For profitWebsite ↗

Also known as: Corvus Pharmaceuticals | Corvus Pharmaceuticals, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Oct 2, 2024

Timeline

2010s

Jun 1, 2014
Corvus Pharmaceuticals, Inc.— Founded

Drugs by trial phase (8 distinct, 9 trials)

Phase 3 (4 own, 0 via acquisition)

Phase 1 (4 own, 0 via acquisition)

Indications

Studied for

Recent trials (17)

NCT06561048Lead sponsorPhase 3Oct 2, 2024
NCT06561048OfficialPhase 3Oct 2, 2024
NCT06345404OfficialPhase 1Apr 30, 2024
NCT06345404Lead sponsorPhase 1Apr 30, 2024
NCT04734873Lead sponsorPhase 3Feb 25, 2021
NCT04734873Study chairPhase 3Feb 25, 2021
NCT04464395Study chairPhase 1Jul 1, 2020
NCT04464395Lead sponsorPhase 1Jul 1, 2020
NCT04280328Study directorPhase 1Feb 28, 2020
NCT04280328Lead sponsorPhase 1Feb 28, 2020
NCT03952078Lead sponsorPhase 1May 3, 2019
NCT03952078Study directorPhase 1May 3, 2019
NCT03454451Lead sponsorPhase 1Apr 25, 2018
NCT03454451Study directorPhase 1Apr 25, 2018
NCT03237988Lead sponsorPhase 1Jul 20, 2017

Details

Founded: Burlingame, CA, US Jun 1, 2014
Last known activity: Oct 2, 2024